Healthcare
Teladoc Health, Inc.(TDOC)
Live Price
Offline$7.34
+0.41% today
1Y Change
+8.12%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $1.17B
- Revenue Growth
- -1.5%
- EPS Growth
- +80.6%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Teladoc Health, Inc. (TDOC) is a Healthcare stock with a market cap of $1.17B and listed on NYSE. The stock last traded around $7.34 and up 8.1% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -1.5%, EPS growth of +80.6%, a dividend yield of 0.0%. What stands out right now is revenue -1.5%, EPS +80.6%, free cash flow +0.9% with operating margin -7.6% and ROIC -7.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TDOC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-1.5% vs +7.6% peer median
Operating Margin
Below sector median
-7.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 29, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -1.5% and EPS is at +80.6%, with operating margin around -7.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +7.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 29, 2026 | โ | +1.8% | +14.3% | +26.2% |
2026 Feb 25, 2026 | +26.3% | +15.1% | +10.3% | +19.8% |
2025 Oct 29, 2025 | +19.2% | +6.2% | -2.1% | -9.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TDOC
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TDOC Max Drawdown
-52.75%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TDOC and SPY.
Company Overview
Teladoc Health, Inc.
New York Stock Exchange
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
- Leadership
- Charles Divita
- IPO Date
- Jun 30, 2015
- Employees
- 4.6k
- Street Address
- 2 Manhattanville Road
- Mailing
- Purchase, NY, 10577
- Region
- Purchase, NY, US
- Reporting Currency
- USD
- Investor Line
- 203 635 2002
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 22.5
- Price/Sales
- 0.5
- Price/Book
- 0.9
Growth
- Revenue
- -1.5%
- EPS
- +80.6%
- Free Cash Flow
- +0.9%
Profitability
- Gross Margin
- 65.6%
- Operating Margin
- -7.6%
- Net Margin
- -6.8%
- ROE
- -12.4%
- ROIC
- -7.4%
Balance Sheet
- Debt/Equity
- 0.77
- Current Ratio
- 2.80
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.